Development and Evaluation of a new technological way of engaging patients and enhancing understanding of drug tolerability in early clinical development: PROACT.
| dc.contributor.author | Hughes, A | |
| dc.contributor.author | Landers, D | |
| dc.contributor.author | Arkenau, H | |
| dc.contributor.author | Shah, S | |
| dc.contributor.author | Stephens, R | |
| dc.contributor.author | Mahal, A | |
| dc.contributor.author | Simmons, M | |
| dc.contributor.author | Lemech, C | |
| dc.contributor.author | Royle, Jennifer | |
| dc.date.accessioned | 2016-06-24T12:03:11Z | |
| dc.date.available | 2016-06-24T12:03:11Z | |
| dc.date.issued | 2016-05-11 | |
| dc.identifier.citation | Development and Evaluation of a new technological way of engaging patients and enhancing understanding of drug tolerability in early clinical development: PROACT. 2016: Adv Ther | en |
| dc.identifier.issn | 1865-8652 | |
| dc.identifier.pmid | 27167621 | |
| dc.identifier.doi | 10.1007/s12325-016-0335-4 | |
| dc.identifier.uri | http://hdl.handle.net/10541/614564 | |
| dc.description.abstract | During early clinical testing of a new medication, it is critical to understand and characterise patient tolerability. However, in early clinical studies, it is difficult for patients to contribute directly to the sponsors' understanding of a new compound. Patient reported opinions about clinical tolerability (PROACT) provides a new, simple and innovative way in which patients can collaborate using an application downloaded to a mobile computer or smartphone. | |
| dc.language | ENG | en |
| dc.language.iso | en | en |
| dc.rights | Archived with thanks to Advances in therapy | en |
| dc.title | Development and Evaluation of a new technological way of engaging patients and enhancing understanding of drug tolerability in early clinical development: PROACT. | en |
| dc.type | Article | en |
| dc.contributor.department | Manchester Cancer Research Centre, University of Manchester, Manchester, UK | en |
| dc.identifier.journal | Advances in Therapy | en |
| html.description.abstract | During early clinical testing of a new medication, it is critical to understand and characterise patient tolerability. However, in early clinical studies, it is difficult for patients to contribute directly to the sponsors' understanding of a new compound. Patient reported opinions about clinical tolerability (PROACT) provides a new, simple and innovative way in which patients can collaborate using an application downloaded to a mobile computer or smartphone. |